Ozone Therapy for Brain Tumors: What the Research Shows

Ozone therapy is being explored as an adjunctive treatment for brain tumors, particularly glioblastoma, though the evidence remains early-stage and largely preclinical. No major medical organization recommends ozone as a standalone cancer treatment. But a small body of research suggests it may enhance the effects of conventional therapies like radiation and chemotherapy.

This article covers what the science actually shows, how ozone is proposed to work against tumor cells, and what patients should know before considering it.

What Is Ozone Therapy?

Ozone therapy involves administering a mixture of ozone (O3) and oxygen (O2) to the body through various routes. In the context of brain tumors, the most studied methods are major autohemotherapy (MAH), where blood is drawn, mixed with ozone, and reinfused, and direct intratumoral injection during or after surgery.

Medical ozone has been used in Europe for decades across various conditions. Its application in oncology, however, remains investigational. The key principle behind ozone in cancer research is that tumor cells and healthy cells respond differently to oxidative stress.

How Ozone May Affect Brain Tumor Cells

Several mechanisms have been proposed for how ozone could influence brain tumor biology.

Selective Oxidative Stress

Cancer cells, including glioblastoma cells, often have impaired antioxidant defenses compared to healthy tissue. When exposed to reactive oxygen species (ROS) generated by ozone, tumor cells may be less equipped to neutralize the oxidative damage. Healthy cells, with intact antioxidant enzyme systems, can typically handle the mild oxidative challenge that low-dose ozone presents.

This selectivity is the theoretical foundation for ozone in oncology. The idea is that ozone creates a level of oxidative stress that overwhelms compromised tumor cells while leaving normal tissue relatively unharmed (Clavo et al., 2018, doi:10.1155/2018/7931849).

Reversing Tumor Hypoxia

Glioblastoma is one of the most hypoxic tumor types. Low oxygen levels within the tumor create resistance to both radiation therapy and certain chemotherapy agents. Radiation, in particular, relies on oxygen to generate the free radicals that damage cancer cell DNA.

Ozone therapy may improve oxygen delivery to the tumor microenvironment. By increasing the partial pressure of oxygen in surrounding tissue, ozone could theoretically sensitize hypoxic tumor cells to radiation, amplifying DNA damage in cancer cells that would otherwise resist treatment (Re et al., 2023, doi:10.3389/fonc.2023.1161206).

Immune Modulation

Ozone at controlled doses can stimulate the production of cytokines and activate immune cells, including natural killer cells and macrophages. In brain tumors, where the immune system is often suppressed by the tumor microenvironment, this immune activation could help the body mount a stronger response against cancer cells.

The Glioblastoma Research

Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor, with a median survival of 15 to 18 months with standard treatment (surgery, radiation, and temozolomide chemotherapy). This poor prognosis drives interest in any adjunctive therapy that might extend survival.

Case Series Data

A case series published in the International Journal of Molecular Sciences examined patients with recurrent high-grade gliomas who received intratumoral ozone-oxygen injections alongside conventional treatment. The median overall survival was 40 months (range: 16 to 53 months), and the median survival following initiation of ozone treatment was 34 months (range: 12 to 53 months). These numbers compare favorably to historical controls, though the small sample size limits conclusions (Megele et al., 2018, doi:10.3389/fonc.2018.00420).

However, a separate study examining six glioblastoma patients found overall survival similar to standard treatment without ozone, including some long-term survivors. The inconsistency between studies highlights the need for larger, controlled trials.

“The limited number of clinical studies and contradictory results highlight the need for further research to fully evaluate the potential benefits and limitations of ozone therapy for glioma.”
Re et al., Frontiers in Oncology, 2023

Combination With Cannabis and Melatonin

A case report published in MDPI documented a glioblastoma patient treated with a combination of medical cannabis, melatonin, and oxygen-ozone therapy. While the patient showed favorable outcomes, single case reports cannot establish efficacy. They can only generate hypotheses for future research.

Delivery Methods for Brain Tumor Patients

When ozone is used in the context of brain tumors, clinicians typically choose from these approaches:

Method	How It Works	Typical Cost
Major Autohemotherapy (MAH)	Blood drawn, ozonated, reinfused	$150 to $300/session
10-Pass Ozone	10 cycles of blood ozonation in one session	$500 to $900/session
Intratumoral Injection	Ozone-oxygen mix injected directly into tumor bed	Varies (surgical setting)
Rectal Insufflation	Ozone gas administered rectally for systemic effects	$75 to $150/session

Intratumoral injection is the method most directly studied for brain tumors. It requires a surgical or interventional setting and is typically performed during craniotomy or via a previously placed catheter. Systemic methods like MAH and 10-pass are used more broadly by integrative oncology practitioners, though direct evidence for their impact on brain tumors is thinner.

What the Evidence Does Not Show

It is important to be direct about the limitations:

• No completed randomized controlled trials have compared ozone therapy plus standard treatment versus standard treatment alone for brain tumors
• No regulatory body has approved ozone therapy for cancer treatment in any form
• Case series are not proof of efficacy. Small, uncontrolled studies cannot account for selection bias, placebo effects, or natural variation in disease course
• Publication bias likely inflates the apparent benefits. Cases where ozone did not help are less likely to be published

The FDA does not approve ozone therapy for any medical condition in the United States. Practitioners who offer it typically do so under the practice of medicine, not under an FDA-approved indication.

Safety Considerations

Ozone therapy, when administered by trained practitioners using calibrated equipment, has a generally favorable safety profile for most applications. However, brain tumor patients face unique considerations:

• Blood-brain barrier disruption: Tumors and prior treatments (surgery, radiation) may alter blood-brain barrier integrity, potentially changing how ozone-derived metabolites reach brain tissue
• Anticoagulation risk: Some brain tumor patients are on blood thinners. Ozone can have mild anticoagulant effects, which must be monitored
• Drug interactions: Patients on temozolomide, bevacizumab, or other cancer drugs should discuss potential interactions with their oncologist
• Seizure threshold: Brain tumor patients may have a lower seizure threshold. While ozone therapy itself is not known to trigger seizures, any physiological perturbation warrants caution

Cost of Ozone Protocols for Cancer Patients

Cancer patients who pursue ozone therapy typically undergo intensive protocols of 10 to 20 sessions, often twice weekly initially, then tapering to weekly maintenance. At these frequencies, costs add up:

• Standard MAH protocol (20 sessions): $3,000 to $6,000
• 10-Pass protocol (10 sessions): $5,000 to $9,000
• Ongoing maintenance (monthly): $150 to $900/month

Insurance does not cover ozone therapy for cancer in the United States. Patients should factor in travel, lodging (if the clinic is not local), and time away from other treatments when calculating total costs.

Important Disclaimers

Ozone therapy should never replace standard-of-care treatment for brain tumors. Surgery, radiation, and chemotherapy remain the evidence-based foundation for managing glioblastoma and other high-grade gliomas.

Any patient considering ozone therapy should:

1. Discuss it openly with their neuro-oncologist before starting
2. Continue all prescribed conventional treatments
3. Choose a practitioner experienced in oncology applications of ozone
4. Understand that the evidence is preliminary and outcomes are not guaranteed
5. Be cautious of any clinic that positions ozone as a cure or primary treatment for brain cancer

The Bottom Line

Ozone therapy for brain tumors sits at the intersection of intriguing preclinical science and insufficient clinical proof. The proposed mechanisms are biologically plausible. Small case series show some encouraging survival numbers. But without randomized controlled trials, it is impossible to know whether ozone is genuinely extending lives or whether other factors explain the results.

For patients with glioblastoma or other high-grade gliomas, the most responsible approach is to pursue ozone therapy only as an adjunct to standard treatment, under the guidance of both an oncologist and a qualified ozone practitioner.

References

• Clavo, B., et al. (2018). Ozone Therapy as Adjuvant for Cancer Treatment: Is Further Research Warranted? Evidence-Based Complementary and Alternative Medicine. doi:10.1155/2018/7931849
• Re, L., et al. (2023). Ozone therapy for high-grade glioma: an overview. Frontiers in Oncology, 13, 1161206. doi:10.3389/fonc.2023.1161206
• Megele, R., et al. (2018). Intra-tumoral treatment with oxygen-ozone in glioblastoma: A systematic literature search and results of a case series. Frontiers in Oncology. doi:10.3389/fonc.2018.00420
• Scassellati, C., et al. (2020). Ozone: A natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders. Ageing Research Reviews, 63, 101138.
• Zanardi, I., et al. (2016). Ozone: A Multifaceted Molecule with Unexpected Therapeutic Activity. Current Medicinal Chemistry, 23(4), 304-314.